Feb 23 (Reuters) - Cyclopharm:
- FY SALES REVENUE OF A$17.70 MILLION, UP 20.6%
- FINAL DIVIDEND MAINTAINED AT 0.5 AU CENTS PER SHARE
- REVENUE FROM TECHNEGAS GENERATOR & PAS SALES IS EXPECTED TO CONTINUE TO REBOUND TO PRE‐PANDEMIC LEVELS OR BEYOND IN 2022
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.08 |
Change
-0.005(0.46%) |
Mkt cap ! $119.4M | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.09 | $1.02 | $9.779K | 9.078K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3106 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 12250 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| CYC (ASX) Chart |